Career
Our solutions
Contact us
Skip to content
About Carasent
Governance
General meeting
Nomination committee
Board of Directors
Management
Remuneration
Auditors
Articles of association
Investor relations
Annual and quarterly reports
Financial calendar
Other documents
The Share
Share buy-back program
Ownership Structure
Relisting to Nasdaq Stockholm 2024
Why invest in Carasent?
Press releases
Career
Our solutions
Contact us
About Carasent
Governance
General meeting
Nomination committee
Board of Directors
Management
Remuneration
Auditors
Articles of association
Investor relations
Annual and quarterly reports
Financial calendar
Other documents
The Share
Share buy-back program
Ownership Structure
Relisting to Nasdaq Stockholm 2024
Why invest in Carasent?
Press releases
Listing Regulation
July 12, 2024 - 07:00
Carasent ASA – Q2 2024 report and presentation
Read more
July 8, 2024 - 10:16
Carasent ASA – Invitation to presentation of Q2 2024 results
Read more
June 24, 2024 - 07:00
Carasent group signs contract to supply Ad Curis to Frelsesarmeen
Read more
April 19, 2024 - 01:36
Carasent ASA – Invitation to presentation of Q1 2024 results
Read more
April 16, 2024 - 03:59
Carasent group signs contract to supply Medrave M4 to VGR
Read more
November 30, 2023 - 08:00
Carasent ASA – Resignation of board member
Read more
November 24, 2023 - 12:45
Carasent ASA – Financial calendar
Read more
November 7, 2023 - 10:02
Carasent ASA – Capital Markets Day presentation
Read more
October 23, 2023 - 12:40
Carasent ASA – Invitation to presentation of Q3 2023 results
Read more
Load more
